Morbidity of the neck after head and neck cancer therapy

被引:74
|
作者
van Wilgen, CP
Dijkstra, PU
van der Laan, BFAM
Plukker, JT
Roodenburg, JLN
机构
[1] Univ Groningen Hosp, Dept Oral & Maxillofacial Surg, NL-9700 RB Groningen, Netherlands
[2] Univ Groningen Hosp, Dept Rehabil, Groningen, Netherlands
[3] Univ Groningen Hosp, Dept Otorhinolaryngol, NL-9700 RB Groningen, Netherlands
[4] Univ Groningen Hosp, Dept Surg Oncol, NL-9700 RB Groningen, Netherlands
关键词
head and neck cancer; neck dissection; neck pain; loss of sensation; range of motion;
D O I
10.1002/hed.20008
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Background. Studies on morbidity of the neck after head and neck cancer therapy are scarcely described. Methods. Patients who underwent surgery, including neck dissection, with and without radiation therapy at least 1 year before the study were asked to participate. We assessed neck pain, loss of sensation, range of motion of the cervical spine, and shoulder pain. Results. Of the 220 patients who were invited, 153 (70%) participated in the study. Neck pain was present in 33% of the patients (n = 51), and shoulder pain was present in 37% of the patients (n = 57). Neuropathic pain of the neck was present in 32% (n = 49); myofascial pain, in 46% (n = 70), and joint pain, in 24% (n = 37). Loss of sensation of the neck was present in 65% (n = 99) and was related to type of neck dissection and radiation therapy. Range of motion of the neck was significantly decreased because of the neck dissection and/or radiation therapy in lateral flexion away from the operated side. Conclusions. The occurrences of morbidity of the neck after cancer therapy were considerable and consisted of neck pain, loss of sensation, and decreased range of motion. (C) 2004 Wiley Periodicals, Inc.
引用
收藏
页码:785 / 791
页数:7
相关论文
共 50 条
  • [31] Nutritional Therapy for Head and Neck Cancer
    Pei-Hung Chang
    Kun-Yun Yeh
    Zhaoping Li
    JournalofNutritionalOncology, 2017, 2 (03) : 103 - 113
  • [32] Proton therapy for head neck cancer
    Mali, Shrikant Balasaheb
    ORAL ONCOLOGY, 2015, 51 (02) : E10 - E12
  • [33] Adjuvant therapy in head and neck cancer
    Vikram, B
    CA-A CANCER JOURNAL FOR CLINICIANS, 1998, 48 (04) : 199 - +
  • [34] Gene therapy for head and neck cancer
    Kevin J. Harrington
    Christopher M. Nutting
    Hardev S. Pandha
    Cancer and Metastasis Reviews, 2005, 24 : 147 - 164
  • [35] Electroporation therapy of head and neck cancer
    Panje, WR
    Hier, MP
    Garman, GR
    Harrell, E
    Goldman, A
    Bloch, I
    ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY, 1998, 107 (09): : 779 - 785
  • [36] Electroporation therapy in head and neck cancer
    Burian, M
    Formanek, M
    Regele, H
    ACTA OTO-LARYNGOLOGICA, 2003, 123 (02) : 264 - 268
  • [37] Proton therapy for head and neck cancer
    Lukens, J. Nicholas
    Lin, Alexander
    Hahn, Stephen M.
    CURRENT OPINION IN ONCOLOGY, 2015, 27 (03) : 165 - 171
  • [38] Proton Therapy for Head and Neck Cancer
    Joseph K. Kim
    Jonathan E. Leeman
    Nadeem Riaz
    Sean McBride
    Chiaojung Jillian Tsai
    Nancy Y. Lee
    Current Treatment Options in Oncology, 2018, 19
  • [39] Targeted therapy in head and neck cancer
    Oeztop, Ilhan
    UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI, 2008, 18 (01): : 46 - 56
  • [40] Targeted therapy in head and neck cancer
    Licitra, Lisa
    Bergamini, Cristiana
    Mirabile, Aurora
    Granata, Roberta
    CURRENT OPINION IN OTOLARYNGOLOGY & HEAD AND NECK SURGERY, 2011, 19 (02): : 132 - 137